A new world for weight management with SlimBiome®

In a comprehensive industry analysis by Nutrition Industry Executive (NIE) magazine, OptiBiotix CEO Stephen O’Hara discusses how the surge in appetite-suppressant products and increasing demand for GLP-1 agonists, such as Ozempic and Wegovy, have driven remarkable growth in demand for innovative weight loss solutions like SlimBiome®.